APA (7th ed.) Citation

JO, B., MJ, I., C, L., NR, R., MM, S., AM, A., . . . AN, A. (2026). Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: Phase 4, randomized CONTINUITY trial. Clinical kidney journal, 19(6), sfag158. https://doi.org/10.1093/ckj/sfag158

Chicago Style (17th ed.) Citation

JO, Burton, Izquierdo MJ, Linde C, Robles NR, Sood MM, Allum AM, Eudicone JM, Dahl M, and Amin AN. "Sodium Zirconium Cyclosilicate Post Hospital Discharge to Prevent Hyperkalaemia: Phase 4, Randomized CONTINUITY Trial." Clinical Kidney Journal 19, no. 6 (2026): sfag158. https://doi.org/10.1093/ckj/sfag158.

MLA (9th ed.) Citation

JO, Burton, et al. "Sodium Zirconium Cyclosilicate Post Hospital Discharge to Prevent Hyperkalaemia: Phase 4, Randomized CONTINUITY Trial." Clinical Kidney Journal, vol. 19, no. 6, 2026, p. sfag158, https://doi.org/10.1093/ckj/sfag158.